Radiopharm Theranostics Ltd

NAS:RADXHealthcarenasdaq_composite

$0.9900+2.80%At closeAt close · Tue 20 Oct · ≈ AED 3.64 · Market cap $13.45M · Next earnings Fri 26 Feb

Ratio	FY2021	FY2021	FY2022	FY2023	FY2024	FY2026	Current · undated	YoY
Gross margin	—	100.0%	100.0%	100.0%	1.1%	−175.2%	—	—
Operating margin	—	−225,527.7%	−11,803.3%	−12,238.4%	−1,050.6%	−2,468.4%	−1,050.6%	+1417.7 pts
Net margin	—	−343,550.9%	−11,838.6%	−16,024.3%	−1,055.3%	−1,992.5%	0.0%	+1992.5 pts
EBITDA margin	—	−203,412.5%	−10,668.6%	−14,732.4%	−1,050.4%	−2,370.6%	—	—
Return on equity	386.5%	−48.2%	−78.0%	−170.5%	−85.6%	−218.5%	0.0%	+218.5 pts
Return on assets	−1,441.3%	−36.4%	−46.2%	−66.6%	−44.3%	−89.7%	0.0%	+89.7 pts
Return on capital employed	386.1%	−26.4%	−55.9%	−67.2%	−53.4%	−162.1%	—	—
Debt / equity	−0.5×	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	—
Debt / assets	176.4%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—
Interest coverage	0.0×	−2.1×	−400.8×	−57.0×	−584.6×	−607.9×	—	—
Current ratio	0.2×	3.5×	1.2×	1.3×	2.7×	1.2×	2.7×	+130.0%
Quick ratio	0.2×	3.5×	1.2×	1.3×	2.7×	1.2×	—	—
Cash ratio	0.2×	3.4×	0.9×	1.1×	1.9×	0.2×	1.9×	+790.4%
Asset turnover	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	—	—
Receivables turnover	0.0×	0.2×	0.1×	0.3×	0.3×	0.2×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—

Margins, returns, leverage and liquidityUpdated Tue 30 Jun ·

ⓘ

Current snapshot ratios have no reporting date and are shown separately from fiscal periods.